Table 1.
Clinicopathological variables of enrolled patients with HCC.
| Variable | Value (n = 12) |
|---|---|
| Age (year) | 54.50 ± 9.91 |
| Sex | |
| Male | 10 (83.3) |
| Female | 4 (16.7) |
| Ethnicity | |
| Asian | 12 (100.0) |
| BMI | 18.9 ± 3.0 |
| HBsAg | |
| Negative | 0 (0.0) |
| Positive | 12 (100.0) |
| Liver cirrhosis | |
| No | 2 (16.7) |
| Yes | 10 (83.3) |
| Tumor size (cm) | 8.66 ± 2.80 |
| Number of tumors | |
| Single | 5 (41.7) |
| Multiple | 7 (58.3) |
| Cheng’s PVTT classification | |
| I | 2 (16.7) |
| II | 6 (50.0) |
| III | 4 (33.3) |
| AFP (ng/mL) | |
| ≤400 | 4 (33.3) |
| >400 | 8 (66.7) |
| ALT (U/L) | 68.22 ± 53.82 |
| AST (U/L) | 64.10 ± 35.76 |
| Albumin (g/L) | 40.47 ± 5.45 |
| Child-Pugh classification | |
| A | 11 (91.7) |
| B | 1 (8.3) |
Data are expressed as mean ± standard deviation or n (%). AFP, Alpha-fetoprotein; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; BMI, body mass index; HBsAg, hepatitis B surface antigen; HCC, hepatocellular carcinoma; PVTT, portal vein tumor thrombus.